Table 1 |
||||||
|
Randomized controlled trials of combination estrogen plus progestin postmenopausal hormone therapy and recurrence of breast cancer |
||||||
| Author [ref.] |
Year |
Number of patients randomized |
Number of patients with follow up |
Duration of follow up |
Number of recurrences (hormone therapy/control) |
RR (95% CI) |
|
|
||||||
| Marsden et al. [23] |
2000 |
100 |
83 |
6 months |
2/1 |
2 |
| Holmberg and Anderson [15] |
2004 |
434 |
345 |
2.1 years |
26/7 |
3.3 (1.5–7.4) |
| von Schoultz and Rutqvist [14] |
2005 |
378 |
359 |
4.1 years |
11/13 |
0.82 (0.35–1.9) |
|
|
||||||
|
CI, confidence interval; RR, relative risk. |
||||||
|
Colditz Breast Cancer Research 2005 7:168 doi:10.1186/bcr1272 |
||||||